| Year |
Citation |
Score |
| 2024 |
Ravichandran S, Snyder PJ, Alber J, Kenny MR, Rothstein A, Brown K, Murchison CF, Clay OJ, Roberson ED, Arthur E. Quantifying Putative Retinal Gliosis in Preclinical Alzheimer's Disease. Investigative Ophthalmology & Visual Science. 65: 5. PMID 38696189 DOI: 10.1167/iovs.65.5.5 |
0.604 |
|
| 2023 |
Alber J, Bouwman F, den Haan J, Rissman RA, De Groef L, Koronyo-Hamaoui M, Lengyel I, Thal DR. Retina pathology as a target for biomarkers for Alzheimer's disease: Current status, ophthalmopathological background, challenges, and future directions. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 37917365 DOI: 10.1002/alz.13529 |
0.432 |
|
| 2023 |
Arthur E, Ravichandran S, Snyder PJ, Alber J, Strenger J, Bittner AK, Khankan R, Adams SL, Putnam NM, Lypka KR, Piantino JA, Sinoff S. Retinal mid-peripheral capillary free zones are enlarged in cognitively unimpaired older adults at high risk for Alzheimer's disease. Alzheimer's Research & Therapy. 15: 172. PMID 37828548 DOI: 10.1186/s13195-023-01312-8 |
0.571 |
|
| 2022 |
Cersonsky TEK, Mechery S, Thompson L, Lee A, Alber J, Sarkar IN, Brick LAD. Related amyloid burden and cortical atrophy in individuals with subtle cognitive decline. Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging. PMID 36151065 DOI: 10.1111/jon.13055 |
0.313 |
|
| 2022 |
Cersonsky TEK, Mechery S, Carper MM, Thompson L, Lee A, Alber J, Sarkar IN, Brick LAD. Using the Montreal cognitive assessment to identify individuals with subtle cognitive decline. Neuropsychology. PMID 35511561 DOI: 10.1037/neu0000820 |
0.309 |
|
| 2022 |
Jutten RJ, Thompson L, Sikkes SAM, Maruff P, Molinuevo JL, Zetterberg H, Alber J, Faust D, Gauthier S, Gold M, Harrison J, Lee AKW, Snyder PJ. A Neuropsychological Perspective on Defining Cognitive Impairment in the Clinical Study of Alzheimer's Disease: Towards a More Continuous Approach. Journal of Alzheimer's Disease : Jad. PMID 35124638 DOI: 10.3233/JAD-215098 |
0.584 |
|
| 2021 |
Ngolab J, Donohue M, Belsha A, Salazar J, Cohen P, Jaiswal S, Tan V, Gessert D, Korouri S, Aggarwal NT, Alber J, Johnson K, Jicha G, van Dyck C, Lah J, et al. Feasibility study for detection of retinal amyloid in clinical trials: The Anti-Amyloid Treatment in Asymptomatic Alzheimer's Disease (A4) trial. Alzheimer's & Dementia (Amsterdam, Netherlands). 13: e12199. PMID 34430703 DOI: 10.1002/dad2.12199 |
0.476 |
|
| 2021 |
Arthur E, Alber J, Thompson LI, Sinoff S, Snyder PJ. OCTA reveals remodeling of the peripheral capillary free zones in normal aging. Scientific Reports. 11: 15593. PMID 34341456 DOI: 10.1038/s41598-021-95230-0 |
0.435 |
|
| 2021 |
Alber J, Arthur E, Goldfarb D, Drake J, Boxerman JL, Silver B, Ott BR, Johnson LN, Snyder PJ. The relationship between cerebral and retinal microbleeds in cerebral amyloid angiopathy (CAA): A pilot study. Journal of the Neurological Sciences. 423: 117383. PMID 33684655 DOI: 10.1016/j.jns.2021.117383 |
0.504 |
|
| 2021 |
Alber J, Popescu D, Thompson LI, Tonini GM, Arthur E, Oh H, Correia S, Salloway SP, Lee AK. Safety and Tolerability of APOE Genotyping and Disclosure in Cognitively Normal Volunteers From the Butler Alzheimer's Prevention Registry. Journal of Geriatric Psychiatry and Neurology. 891988721993575. PMID 33550928 DOI: 10.1177/0891988721993575 |
0.439 |
|
| 2020 |
Alber J, Arthur E, Sinoff S, DeBuc DC, Chew EY, Douquette L, Hatch WV, Hudson C, Kashani A, Lee CS, Montaquila S, Mozdbar S, Cunha LP, Tayyari F, Van Stavern G, et al. A recommended "minimum data set" framework for SD-OCT retinal image acquisition and analysis from the Atlas of Retinal Imaging in Alzheimer's Study (ARIAS). Alzheimer's & Dementia (Amsterdam, Netherlands). 12: e12119. PMID 33163610 DOI: 10.1002/dad2.12119 |
0.575 |
|
| 2020 |
Snyder PJ, Alber J, Alt C, Bain LJ, Bouma BE, Bouwman FH, DeBuc DC, Campbell MCW, Carrillo MC, Chew EY, Cordeiro MF, Dueñas MR, Fernández BM, Koronyo-Hamaoui M, La Morgia C, et al. Retinal imaging in Alzheimer's and neurodegenerative diseases. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. PMID 33090722 DOI: 10.1002/alz.12179 |
0.601 |
|
| 2020 |
Alber J, Maruff P, Santos CY, Ott BR, Salloway SP, Yoo DC, Noto RB, Thompson LI, Goldfarb D, Arthur E, Song A, Snyder PJ. Disruption of cholinergic neurotransmission, within a cognitive challenge paradigm, is indicative of Aβ-related cognitive impairment in preclinical Alzheimer's disease after a 27-month delay interval. Alzheimer's Research & Therapy. 12: 31. PMID 32209123 DOI: 10.1186/S13195-020-00599-1 |
0.698 |
|
| 2020 |
Alber J, Goldfarb D, Thompson LI, Arthur E, Hernandez K, Cheng D, DeBuc DC, Cordeiro F, Provetti-Cunha L, den Haan J, Van Stavern GP, Salloway SP, Sinoff S, Snyder PJ. Developing retinal biomarkers for the earliest stages of Alzheimer's disease: What we know, what we don't, and how to move forward. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 16: 229-243. PMID 31914225 DOI: 10.1002/Alz.12006 |
0.668 |
|
| 2020 |
Alber J, Arthur E, Thompson LI, Goldfarb D, Fernandez BM, Salloway SP, Sinoff S, Snyder PJ. The Atlas of Retinal Imaging in Alzheimer’s Study (ARIAS): Study design and objectives Alzheimer's & Dementia. 16. DOI: 10.1002/alz.045325 |
0.406 |
|
| 2020 |
Aker R, Arthur E, Thompson LI, Maruff PT, Snyder PJ, Alber J. Development of the Snellen Memory Test (SMT): An episodic memory test to screen for AD risk in a clinical optometry/ophthalmology setting Alzheimer's & Dementia. 16. DOI: 10.1002/alz.045307 |
0.422 |
|
| 2019 |
Alber J, Alladi S, Bae HJ, Barton DA, Beckett LA, Bell JM, Berman SE, Biessels GJ, Black SE, Bos I, Bowman GL, Brai E, Brickman AM, Callahan BL, Corriveau RA, et al. White matter hyperintensities in vascular contributions to cognitive impairment and dementia (VCID): Knowledge gaps and opportunities. Alzheimer's & Dementia (New York, N. Y.). 5: 107-117. PMID 31011621 DOI: 10.1016/J.Trci.2019.02.001 |
0.448 |
|
| 2019 |
Thompson LI, Lee AKW, Williams R, Salloway S, Alber J. P4-375: Subjective Cognitive Decline Before And After Apoe And Amyloid Pet Disclosure In Cognitively Normal Older Adults Screening For Alzheimer'S Disease Prevention Trials Alzheimers & Dementia. 15. DOI: 10.1016/J.Jalz.2019.06.4046 |
0.488 |
|
| 2018 |
Alber J, McGarry K, Noto RB, Snyder PJ. Use of Eflornithine (DFMO) in the Treatment of Early Alzheimer's Disease: A Compassionate Use, Single-Case Study. Frontiers in Aging Neuroscience. 10: 60. PMID 29559907 DOI: 10.3389/Fnagi.2018.00060 |
0.618 |
|
| 2018 |
Thompson LI, Alber J, Hernandez KA, Snyder PJ. P1-530: Dctclock™ Versus Manual 10-Point Scoring Method In Predicting Amyloid Burden And Memory Performance In Healthy Older Adults With Subjective Cognitive Complaints Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.541 |
0.513 |
|
| 2018 |
Alber J, Goldfarb D, Drake J, Silver B, Ott BR, Snyder PJ. P1-292: Retinal Changes In Cerebral Amyloid Angiopathy (Caa): Relationship To Cerebral Pathology Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.298 |
0.538 |
|
| 2018 |
Lee AKW, Thompson LI, Collier MK, Goldfarb D, Dawson B, Salloway S, Alber J. P3-020: The Effects Of Subjective Cognitive Decline On Apoe Genotype Disclosure In The Butler Alzheimer'S Prevention Registry Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1375 |
0.459 |
|
| 2018 |
Alber J, Collier MK, Goldfarb D, Thompson LI, Dawson B, Salloway S, Lee AK. P2-644: Safety, Tolerability, And Lifestyle Changes Associated With Apoe Disclosure In The Butler Alzheimer'S Prevention Registry: Implications For Recruitment To Clinical Trials Alzheimers & Dementia. 14. DOI: 10.1016/J.Jalz.2018.06.1340 |
0.357 |
|
| 2017 |
Santos CY, Snyder PJ, Wu WC, Zhang M, Echeverria A, Alber J. Pathophysiologic relationship between Alzheimer's disease, cerebrovascular disease, and cardiovascular risk: A review and synthesis. Alzheimer's & Dementia (Amsterdam, Netherlands). 7: 69-87. PMID 28275702 DOI: 10.1016/J.Dadm.2017.01.005 |
0.664 |
|
| 2017 |
Alber J, Silver B, Ott BR, Snyder PJ. A Potential Retinal Biomarker Of Cerebral Amyloid Angiopathy Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.895 |
0.561 |
|
| 2017 |
Lee A, Alber J, Monast D, Menard W, Tang T, Bodge C, Malloy P, Salloway S. The Butler Alzheimer'S Prevention Registry: Recruitment And Interim Outcome Alzheimers & Dementia. 13. DOI: 10.1016/J.Jalz.2017.06.695 |
0.363 |
|
| 2017 |
Alber J, McGarry K, Noto RB, Snyder PJ. Use Of Eflornithine (Dfmo) In The Treatment Of Mild Alzheimer’S Disease: A Compassionate Use Single-Case Study Alzheimers & Dementia. 13: 263. DOI: 10.1016/J.Jalz.2017.06.134 |
0.467 |
|
| 2016 |
Snyder PJ, Johnson LN, Lim YY, Santos CY, Alber J, Maruff P, Fernández B. Nonvascular retinal imaging markers of preclinical Alzheimer's disease. Alzheimer's & Dementia (Amsterdam, Netherlands). 4: 169-178. PMID 27830174 DOI: 10.1016/J.Dadm.2016.09.001 |
0.696 |
|
| 2014 |
Alber J, Della Sala S, Dewar M. Minimizing interference with early consolidation boosts 7-day retention in amnesic patients. Neuropsychology. 28: 667-75. PMID 24819064 DOI: 10.1037/Neu0000091 |
0.35 |
|
| 2006 |
Goldfarb D, Snyder PJ, Maruff P, Santos CY, Ott BR, Salloway S, Yoo DC, Noto RB, Alber J, Thompson LI, Song A. P1-132: DISRUPTION OF CHOLINERGIC NEUROTRANSMISSION, WITHIN A COGNITIVE CHALLENGE PARADIGM, PREDICTS Aβ-RELATED COGNITIVE IMPAIRMENT IN PRECLINICAL ALZHEIMER'S DISEASE AFTER A 27-MONTH DELAY INTERVAL Alzheimer's & Dementia. 14: P322-P323. DOI: 10.1016/J.Jalz.2018.06.135 |
0.662 |
|
| Show low-probability matches. |